Helen Devonport

Bradford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Modified Delphi expert consensus on the optimal intravitreal treatment pathway for centre involving diabetic macular oedema patients within the National Health Service.

Modified Delphi expert consensus on the optimal intravitreal treatment pathway for centre involving diabetic macular oedema patients within the National Health Service.

Journal: BMJ open ophthalmology

Published: February 08, 2026

Pertussis Infection and Bilateral Optic Neuropathy Leading to Blindness in a 68-Year-old Male Patient: Possible Link or a Coincidence?

Pertussis Infection and Bilateral Optic Neuropathy Leading to Blindness in a 68-Year-old Male Patient: Possible Link or a Coincidence?

Journal: Cureus

Published: January 16, 2026

Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.

Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.

Journal: Journal of ophthalmic inflammation and infection

Published: January 08, 2025

Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.

Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.

Journal: Journal of ophthalmic inflammation and infection

Published: October 24, 2023

Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting.

Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: October 29, 2022

Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.

Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.

Journal: BMJ open ophthalmology

Published: December 22, 2020

Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration.

Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration.

Journal: Eye (London, England)

Published: September 17, 2019

Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service.

Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service.

Journal: Eye (London, England)

Published: March 31, 2019

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: November 30, 2017

Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel.

Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel.

Journal: Eye (London, England)

Published: July 10, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026